Deep-pocketed investors have adopted a bullish approach towards BridgeBio Pharma (NASDAQ:BBIO), and it’s something market players shouldn’t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BBIO usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga’s options scanner highlighted 9 extraordinary options activities for BridgeBio Pharma. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 3 are puts, totaling $1,085,600, and 6 are calls, amounting to $400,980.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $55.0 for BridgeBio Pharma during the past quarter.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for BridgeBio Pharma’s options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of BridgeBio Pharma’s whale trades within a strike price range from $30.0 to $55.0 in the last 30 days.
BridgeBio Pharma Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BBIO | PUT | TRADE | BULLISH | 08/16/24 | $6.0 | $4.1 | $4.6 | $30.00 | $920.0K | 654 | 0 |
| BBIO | PUT | SWEEP | BEARISH | 08/16/24 | $11.5 | $11.4 | $11.5 | $40.00 | $136.8K | 247 | 145 |
| BBIO | CALL | TRADE | BULLISH | 08/16/24 | $0.45 | $0.0 | $0.45 | $55.00 | $112.5K | 5.5K | 0 |
| BBIO | CALL | SWEEP | BULLISH | 08/16/24 | $3.1 | $3.0 | $3.1 | $35.00 | $100.1K | 3.0K | 644 |
| BBIO | CALL | SWEEP | NEUTRAL | 08/16/24 | $1.65 | $1.2 | $1.6 | $40.00 | $80.0K | 6.1K | 500 |
About BridgeBio Pharma
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology,…
Click Here to Read the Full Original Article at Cryptocurrencies Feed…
